L K Heilbrun - JoVE Visualize

Showing results (51-60 of 88) with videos related to

Pageof 9

Sort By:

Journal of the American Dietetic Association|May 23, 1998

Oxidative DNA damage levels in blood from women at high risk for breast cancer are associated with dietary intakes of meats, vegetables, and fruitsZ Djuric, J B Depper, V Uhley, et al.

Southern Medical Journal|September 1, 1980

Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic diseaseA Y Bedikian, M Valdivieso, L K Heilbrun, et al.

Obstetrics and Gynecology|April 1, 1986

Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalenceR D Wasnich, P D Ross, L K Heilbrun, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.

Cancer|February 15, 1996

Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from blood as a marker of breast cancerZ Djuric, L K Heilbrun, M S Simon, et al.

European Urology|January 1, 1996

Age and racial distribution of prostatic intraepithelial neoplasiaW A Sakr, D J Grignon, G P Haas, et al.

Investigational New Drugs|September 18, 1998

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994

Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaF A Momin, M Zalupski, L K Heilbrun, et al.

Nutrition and Cancer|April 19, 2002

Comparison of dietary assessment methods in a low-fat dietary intervention programM S Simon, S Lababidi, Z Djuric, et al.

Urology|May 1, 1997

The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical marginsI J Powell, L K Heilbrun, W Sakr, et al.

Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:

Pageof 9

Journal of the American Dietetic Association|May 23, 1998

Oxidative DNA damage levels in blood from women at high risk for breast cancer are associated with dietary intakes of meats, vegetables, and fruitsZ Djuric, J B Depper, V Uhley, et al.

Southern Medical Journal|September 1, 1980

Glycerol: an alternative to dexamethasone for patients receiving brain irradiation for metastatic diseaseA Y Bedikian, M Valdivieso, L K Heilbrun, et al.

Obstetrics and Gynecology|April 1, 1986

Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalenceR D Wasnich, P D Ross, L K Heilbrun, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.

Cancer|February 15, 1996

Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from blood as a marker of breast cancerZ Djuric, L K Heilbrun, M S Simon, et al.

European Urology|January 1, 1996

Age and racial distribution of prostatic intraepithelial neoplasiaW A Sakr, D J Grignon, G P Haas, et al.

Investigational New Drugs|September 18, 1998

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinomaM M Zalupski, A F Shields, P A Philip, et al.

Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994

Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaF A Momin, M Zalupski, L K Heilbrun, et al.

Nutrition and Cancer|April 19, 2002

Comparison of dietary assessment methods in a low-fat dietary intervention programM S Simon, S Lababidi, Z Djuric, et al.

Urology|May 1, 1997

The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical marginsI J Powell, L K Heilbrun, W Sakr, et al.

Pageof 9